Explain this page
Arphra AIPlain-English read on Nuvalent, Inc.’s valuation06-09today
- NUVL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Nuvalent to GSK2d
- NUVL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Nuvalent to GSK2d
- Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL8d
- Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL8d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $132.74 (+7.54%)
Candlestick · 1Y
Open in chart workstation →NUVL
123.35+17.53%H 123.62L 89.20MA50 103.30MA200 —Avg vol 1.6M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.06% | +0.06% | +22.21% | +27.17% | +18.91% | +22.71% | +64.57% | +181.93% | +558.29% | +558.29% | +558.29% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$123.43
Bid
$123.16
2 sh
Ask
$125.10
1 sh
Spread
$1.940
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Technology+2.51%
- Communication Services+1.85%
- Utilities+1.35%
- Consumer Cyclical+0.30%
- Consumer Defensive-0.30%
- Energy-0.45%
- Industrials-0.48%
- Basic Materials-0.66%
- Financial Services-0.67%
- Real Estate-0.99%
- Healthcare-1.51%
Top industries (issuer's industry highlighted)
- Biotechnology+0.28%
- Oil & Gas Energy+8.53%
- Business Equipment & Supplies+5.82%
- Semiconductors+5.24%
- Electronic Gaming & Multimedia+5.23%
- Advertising Agencies-5.20%
- Medical - Equipment & Services+5.08%
- Grocery Stores-4.35%
- Financial - Mortgages+4.08%
- Broadcasting+4.00%
- Computer Hardware-3.67%
- Internet Content & Information+3.58%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- NUVL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Nuvalent to GSKglobenewswire.com·Jun 16, 2026
- NUVL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Nuvalent to GSKglobenewswire.com·Jun 16, 2026
- Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVLbusinesswire.com·Jun 10, 2026
- Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVLbusinesswire.com·Jun 10, 2026
- Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholdersgurufocus.com·Jun 10, 2026
- Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholdersprnewswire.com·Jun 10, 2026
- Shareholder Alert: Ademi LLP investigates whether Nuvalent, Inc. is obtaining a Fair Price for Public Shareholdersprnewswire.com·Jun 10, 2026
- Halper Sadeh LLC is Investigating Whether NUVL, SUNE, OGN, TMHC are Obtaining Fair Deals for their Shareholdersglobenewswire.com·Jun 09, 2026
Recent analyst activity
DB- Jun 10, 2026GradeOutperform → OutperformBernstein SocGen on Nuvalent (NUVL): 'Extremely rare value creation by large cap pharma M&A'Bernstein
- Jun 10, 2026GradeBuy → NeutralNuvalent downgraded to Neutral from Buy at GuggenheimGuggenheim
- Jun 10, 2026PT$124.00Nuvalent downgraded to Neutral from Buy at GuggenheimGuggenheim
- Jun 10, 2026GradeBuy → NeutralNuvalent downgraded to Neutral from Buy at UBSUBS
- Jun 10, 2026PT$124.00UBS Downgrades Nuvalent (NUVL) to NeutralUBS
- Jun 09, 2026PT$124.00Nuvalent downgraded to Hold from Buy at TruistTruist Financial
- Jun 09, 2026GradeBuy → HoldNuvalent downgraded to Hold from Buy at TD CowenCowen & Co.
- Jun 09, 2026PT$124.00Nuvalent downgraded to Equal Weight from Overweight at BarclaysBarclays
- Jun 09, 2026PT$122.85Nuvalent downgraded to Neutral from Outperform at BairdRobert W. Baird
- Jun 09, 2026PT$124.00Nuvalent downgraded to Hold from Buy at StifelStifel Nicolaus
- Jun 09, 2026GradeOutperform → Market PerformNuvalent downgraded to Market Perform from Outperform at Raymond JamesRaymond James
- Jun 09, 2026PT$124.00Nuvalent downgraded to Equal Weight from Overweight at Wells FargoWells Fargo
- Jun 09, 2026PT$124.00Nuvalent downgraded to Neutral from Buy at H.C. WainwrightH.C. Wainwright
- Jun 09, 2026GradeBuy → NeutralNuvalent downgraded to Neutral from Buy at H.C. WainwrightH.C. Wainwright
- Jun 09, 2026GradeOverweight → NeutralNuvalent downgraded to Neutral from Overweight at Piper SandlerPiper Sandler
Peers
No peer list available for NUVL.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|